Neuroscience Letters 1990-05-04

Duodenal SP-like immunoreactivity is decreased in experimentally-induced duodenal ulcers.

S Evangelista, D Renzi, P Mantellini, C Surrenti, A Meli

Index: Neurosci. Lett. 112(2-3) , 352-5, (1990)

Full Text: HTML

Abstract

Substance P-like immunoreactivity (SP-li) is decreased in duodenal samples of animals treated with a single dose of an ulcerogen such as dulcerozine, mepirizole or cysteamine. Unlike dulcerozine- or mepirizole-induced ulcers the degree of cysteamine-induced duodenal lesions is inversely correlated with the levels of duodenal SP-li. A significant decrease in duodenal SP-li was observed at 24 h, but not at 6 h after a single oral dose of cysteamine. These findings show that endogenous SP may play an important local role in duodenal ulcerogenesis.

Related Compounds

  • Epirizole

Related Articles:

Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation.

2011-11-29

[Proc. Natl. Acad. Sci. U. S. A. 108(48) , 19264-9, (2011)]

Role of active oxygen species and lipid peroxidation in mepirizole-induced duodenal ulcers in rats.

1998-08-01

[Dig. Dis. Sci. 43(8) , 1657-64, (1998)]

Tobacco cigarette smoke attenuates duodenal ulcer margin hyperemia in the rat. Comparison of IAP clearance and hydrogen gas clearance techniques for measurements of gastrointestinal blood flow.

1995-05-01

[Dig. Dis. Sci. 40(5) , 1112-7, (1995)]

Effects of pituitary adenylate cyclase activating polypeptide-27 on alkaline secretory and mucosal ulcerogenic responses in rat duodenum.

1998-01-01

[Life Sci. 63(5) , 317-25, (1998)]

Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.

1993-08-01

[Jpn. J. Pharmacol. 62(4) , 363-71, (1993)]

More Articles...